logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

John E Toth

This inventor holds 21 USPTO granted patents, primarily in Antitumor Compositions. Top assignees: Eli Lilly and Company, University of Hawai'i, Wayne State University. Active years: 1984-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John E Toth. Retrieved from https://idiyas.com/inventor/john-e-toth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 90.5

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 70(Granted Patents)


Location History:

  • West Lafayette, IN (US) (1984)
  • Indianapolis, IN (US) (1984 - 2009)

Company Filing History:

goldMedal20 out of 4,517 
 
Eli Lilly and Company
 patents
silverMedal1 out of 268 
 
University of Hawai'i
 patents
bronzeMedal1 out of 603 
 
Wayne State University
 patents
4. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2009

Loading Chart...
Areas of Expertise:
Antitumor Compositions
Antithrombotic Agents
Mixed Lineage Kinase Modulators
Cryptophycin Compounds
Macrolide Derivatives
Sulfonimidamides
Pharmaceutical Compositions
Novel Intermediates
23-Monoesters
C-20-Modified Derivatives
C-23-Modified Derivatives
Loracarbef Hydrochloride
21 patents (USPTO):Explore Patents
1. 7511065 - Mixed lineage kinase modulators (2009-03-31),
2. 6680311 - Cryptophycin compounds (2004-01-20),
3. 6620837 - Antithrombotic agents (2003-09-16),
4. 6174921 - Antitumor compositions and methods of treatment (2001-01-16),
5. 6133262 - Antithrombotic agents (2000-10-17),
6. 6020512 - Process and novel intermediates (2000-02-01),
7. 5827879 - Antitumor compositions and methods of treatment (1998-10-27),
8. 5578720 - Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof (1996-11-26),
9. 5565494 - Antitumor compositions and methods of treatment (1996-10-15),
10. 5550231 - Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof (1996-08-27),
11. 5529999 - Antitumor compositions and methods of treatment (1996-06-25),
12. 5354778 - Antitumor compositions and methods of treatment (1994-10-11),
13. 5262440 - Antitumor compositions and methods of treatment (1993-11-16),
14. 5258406 - Sulfonimidamides (1993-11-02),
15. 5254582 - Antitumor compositions and methods (1993-10-19),

Title: The Innovative Journey of Inventor John E Toth

Introduction:

John E Toth, an inventive mind hailing from Indianapolis, IN (US), has left a remarkable impact in the world of patents with a total of 21 patents to his name.

Latest Patents:

His recent patents include groundbreaking contributions such as Mixed Lineage Kinase Modulators, offering new possibilities in the treatment of physiological disorders like congestive heart disease. Additionally, Toth's work on Cryptophycin Compounds showcases his versatility and expertise in the field of pharmaceuticals.

Career Highlights:

Throughout his career, John E Toth has made significant strides in the pharmaceutical industry. Notable companies in which he has applied his innovative talents include Eli Lilly and Company.

Collaborations:

Collaborating with accomplished professionals like James E Ray and Herbert A Kirst, Toth has demonstrated his ability to work effectively in a team, bringing diverse perspectives and expertise to his innovative endeavors.

Conclusion:

In conclusion, John E Toth stands as a pioneering inventor whose passion for creating solutions to complex problems has earned him a well-deserved reputation in the world of patents. His dedication to advancing healthcare through innovative pharmaceutical formulations continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…